| Literature DB >> 35449560 |
Qianwen Wu1, Tingting Peng1, Liru Liu1, Peishan Zeng1, Yunxian Xu1, Xubo Yang1, Yiting Zhao1, Chaoqiong Fu1, Shiya Huang1, Yuan Huang1,2, Hongyu Zhou1, Yun Liu3, Hongmei Tang1, Lu He1, Kaishou Xu1.
Abstract
Constraint-induced movement therapy (CIMT) combined with repetitive transcranial magnetic stimulation (rTMS) have shown great potential in improving function in schoolchildren with unilateral cerebral palsy attributed to perinatal stroke. However, the prospect of application in preschool children with unilateral cerebral palsy (UCP) attributed to various brain disorders remains unclear. In this prospective, assessor-blinded, randomized controlled study, 40 preschool children with UCP (aged 2.5-6 years) were randomized to receive 10 days of CIMT combined with active or sham rTMS. Assessments were performed at baseline, 2 weeks, and 6 months post-intervention to investigate upper limb extremity, social life ability, and perceived changes by parents and motor-evoked potentials. Overall, 35 participants completed the trial. The CIMT plus active stimulation group had greater gains in the affected hand function (range of motion, accuracy, and fluency) than the CIMT plus sham stimulation group (P < 0.05), but there was no significant difference in muscular tone, social life ability, and perceived changes by parents between the two groups (P > 0.05). In addition, there was no significant difference in hand function between children with and without motor-evoked potential (P > 0.05). No participants reported severe adverse events during the study session. In short, the treatment of CIMT combined with rTMS is safe and feasible for preschool children with UCP attributed to various brain disorders. Randomized controlled studies with large samples and long-term effects are warranted.Entities:
Keywords: constraint-induced movement therapy; hand function; preschool children; repetitive transcranial magnetic stimulation; unilateral cerebral palsy
Year: 2022 PMID: 35449560 PMCID: PMC9017424 DOI: 10.3389/fnbeh.2022.876567
Source DB: PubMed Journal: Front Behav Neurosci ISSN: 1662-5153 Impact factor: 3.558
Figure 1Study flow diagram.
Baseline participant characteristics by the group.
|
|
|
| |
|---|---|---|---|
| Age (m) | 50.6 (10.5) | 43.83 (12.6) | 0.123 |
| Gender, male/female | 6/11 | 8/10 | 0.594 |
| Left side of hemiparesis, | 8 (47.1) | 10 (55.6) | 0.620 |
| Gross motor function classification system, level I/II | 15/2 | 13/5 | 0.249 |
| Manual ability classification system, level I/II | 11/6 | 8/10 | 0.236 |
| The modified Ashworth scale, median (range) | 1+ (1–3) | 2 (1–3) | 0.756 |
|
| |||
| Range of motion | 72.77 (17.37) | 68.90 (19.05) | 0.535 |
| Accuracy | 82.59 (15.16) | 74.49 (19.20) | 0.177 |
| Dexterity | 65.03 (15.34) | 59.18 (15.52) | 0.271 |
| Fluency | 70.31 (13.21) | 62.15 (11.85) | 0.052 |
| SCUES of affected side | 8.71 (2.4) | 8.17 (3.6) | 0.603 |
| SCUES of the unaffected side | 14.00 (2.3) | 14.17 (1.7) | 0.465 |
| Global rating scale | 4.76 (1.8) | 4.11 (1.9) | 0.304 |
| Standard scores of social life ability scale | 10 (1.2) | 10 (1.4) | 0.930 |
| Magnetic resonance imaging ( | PVL (6), ventricle broadening (3), cyst (1); normal (1), absence (6) | PVL (9); ventricle broadening (4); cyst (2); absence (3) | |
P-value represents between-group differences. Data shown are means (SD) or n (%), unless otherwise stated.
CIMT, constraint-induced movement therapy; rTMS, repetitive transcranial magnetic stimulation; SCUES, selective control of upper extremity scale; PVL, periventricular leukomalacia.
Pre- and post-intervention changes in the Melbourne Assessment 2 in the 2 treatment groups.
|
|
|
|
|
|
|---|---|---|---|---|
| MA2-range of motion | Baseline | 72.77 (17.4) | 68.90 (19.0) |
|
| 2 Weeks | 83.44 (13.7) | 75.36 (20.5) | ||
| 6 Months | 81.25 (14.4) | 71.80 (16.1) | ||
| MA2-accuracy | Baseline | 82.59 (15.2) | 74.44 (19.2) |
|
| 2 Weeks | 90.35 (10.5) | 82.89 (19.1) | ||
| 6 Months | 90.59 (10.6) | 80.4 (19.3) | ||
| MA2-dexterity | Baseline | 65.03 (15.3) | 59.18 (15.5) | 0.356 |
| 2 weeks | 78.28 (14.2) | 64.06 (13.8) | ||
| 6 months | 73.49 (13.4) | 65.25 (13.7) | ||
| MA2-fluency | Baseline | 70.31 (13.2) | 62.15 (11.8) |
|
| 2 Weeks | 79.83 (11.1) | 74.60 (11.4) | ||
| 6 Months | 79.27 (12.8) | 68.26 (11.0) | ||
| SCUES (affected) | Baseline | 8.71 (2.4) | 8.17 (3.6) | 0.742 |
| 2 Weeks | 12.59 (2.5) | 11.28 (3.5) | ||
| 6 Months | 10.76 (2.2) | 9.56 (2.5) | ||
| SCUES (unaffected) | Baseline | 14.00 (2.3) | 14.17 (1.7) | 0.451 |
| 2 Weeks | 13.24 (2.4) | 12.94 (3.6) | ||
| 6 Months | 14.06 (1.5) | 13.89 (1.2) |
P-value represents between-group differences (the bold values represent P <0.05). Values are reported as mean (SD). Within-group and between-group differences were analyzed with repeated measures analyses of variance.
Significantly different than baseline, P <0.05.
Significantly different than baseline, P <0.01.
CIMT, constraint-induced movement therapy; rTMS, repetitive transcranial magnetic stimulation; MA2, the modified Melbourne assessment 2; SCUES, selective control of upper extremity scale.
Figure 2Changes of muscle tone of the affected upper extremity in the constraint-induced movement therapy (CIMT) plus active stimulation group and sham stimulation group. (A) Muscle tone of forearm. (B) Muscle tone of wrist. (C) Muscle tone of thumb. (D) Muscle tone of the other fingers. rTMS, repetitive transcranial magnetic stimulation.
Figure 3Perceived changes by caregivers and changes of activity of daily living in the constraint induced movement therapy (CIMT) plus active stimulation group and sham stimulation group. (A) Changes of global rating scale. (B) Changes of social life ability scale for Chinese infant-junior school student. rTMS, repetitive transcranial magnetic stimulation.
Comparison of upper extremity function between the groups with or without MEPs at 2 weeks of postintervention.
|
|
|
|
|
|
|---|---|---|---|---|
| MA2-range of motion | Baseline | 80.42 (4.90) | 78.27 (8.51) | 0.826 |
| 2 Weeks | 87.83 (4.41) | 82.54 (6.40) | ||
| MA2-accuracy | Baseline | 76.57 (18.82) | 86.86 (13.41) | 0.426 |
| 2 Weeks | 88.57 (13.35) | 90.29 (9.48) | ||
| MA2-dexterity | Baseline | 58.64 (18.59) | 74.47(8.24) | 0.381 |
| 2 Weeks | 78.59 (19.39) | 82.57 (8.42) | ||
| MA2-fluency | Baseline | 69.38 (17.14) | 75.51 (9.29) | 0.329 |
| 2 Weeks | 74.53 (19.48) | 80.03 (6.40) | ||
| SCUES (affected) | Baseline | 7.71 (2.36) | 10.00 (1.91) | 0.648 |
| 2 Weeks | 12.71 (2.87) | 13.43 (2.15) | ||
| SCUES (unaffected) | Baseline | 14.29 (1.89) | 15.00 (0.00) | 0.288 |
| 2 Weeks | 12.71 (2.87) | 13.86 (2.27) |
Values are reported as mean (SD).
MEP, motor-evoked potential; CIMT, constraint-induced movement therapy; rTMS, repetitive transcranial magnetic stimulation.